News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Barclays analyst James Rose has reaffirmed a Buy rating on Rentokil Initial (RTO) with a price target of £6.30. This positive sentiment is supported by the company's recent strong financial performance, reporting increased quarterly revenue and net profit. Corporate insider sentiment is also positive, …
Sharemaestro market context Price below Trend Line 52 weeks -1.1%Rentokil Initial PLC (NYSE:RTO) has received a "Moderate Buy" consensus rating from fourteen analysts, with an average 12-month price target of $31.90. The company's shares opened at $24.72, below its moving averages and near its 12-month low, and it recently declared a dividend of …
Kenneth R. Lehman has filed an amended Schedule 13G indicating he no longer holds a reportable position in Affinity Bancshares, Inc. common stock. The filing states he now beneficially owns 0 shares, representing 0% of the class, with no sole or shared voting or …
Affinity Bancshares, Inc. director Shore Teak disposed of 20,000 shares of common stock on August 1, 2026, as part of a merger agreement. Each share was converted into the right to receive $23.00 in cash, leaving Teak with no reported shares. This transaction was …
Affinity Bancshares CEO Edward John Cooney reported the conversion of his equity holdings into cash as part of a merger agreement dated March 30, 2026. Under the agreement, each share of common stock was converted into the right to receive $23.00 in cash, and …
Affinity Bancshares, Inc.'s EVP and CCO, Nelson Clark, reported the disposition of his equity as part of a merger. His common shares, including those held directly and indirectly, were converted into the right to receive $23.00 cash per share. Additionally, his stock options were …
Affinity Bancshares director Edward P. Stone disposed of all his reported common shares and stock options on August 1, 2026, in connection with a merger agreement dated March 30, 2026. Under the terms of the merger, each common share was converted into the right …
Affinity Bancshares, Inc. director Robin S. Reich fully cashed out her equity holdings in the company as part of a merger agreement dated March 30, 2026. Her 24,494 common stock shares and all stock options were converted into the right to receive $23.00 cash …
Definitive Healthcare (Nasdaq: DH) has announced an early adopter program for its new AI-powered healthcare intelligence platform, providing select organizations with early access. The platform integrates claims, provider, consumer, and expert data with conversational AI to surface insights, optimize market opportunities, and improve decision-making. …
Trinity Capital (TRIN) announced strong second-quarter 2026 results, with total investment income up 25.5% year-over-year to $87.2 million and record net investment income of $46.0 million ($0.51 per share). The company maintained credit quality, increased its investment portfolio, and declared consistent monthly dividends of …
Rentokil Initial announced that Janus Henderson Group Ltd reduced its stake in the company below the 5% regulatory threshold to 4.995% of voting rights, down from 5.232%. This move, disclosed on July 30, 2026, and filed with the SEC on August 4, 2026, may …
Analysts from Bank of America Securities have issued bullish sentiments for several industrial goods stocks. Ronald Epstein maintained a Buy rating for RTX with a Strong Buy consensus and a 7.9% upside. Tim Ramskill also kept a Buy rating on Rentokil Initial, which holds …
This page provides financial information, specifically the price to earnings ratio, for Trinity Capital Inc. 7.875% Notes due 2029 (TRNZ). It is listed on the Blue Ocean Alternative Trade System (BOATS) and is accessible via TradingView, offering an overview of its financials.
Trinity Capital (NASDAQ: TRIN) reported robust financial results for Q2 2026, showing significant increases in total investment income and net investment income, alongside a rise in Net Asset Value per share. The company funded $618.7 million in investments and originated $709.0 million in new …
Trinity Capital Inc. (NYSE:TRIN) stock closed at $17.24, down 5.07% on August 5, 2026. The company reported its Q2 earnings call highlights, including record originations and growth in net asset value, along with expanding managed-funds and a recent equipment-finance acquisition. Trinity Capital is publicly …
Trinity Capital (NYSE:TRIN) reported record origination activity in Q2 2026, with $618.7 million in fundings, despite missing Wall Street's earnings and revenue estimates. The company emphasized its diversified lending platform, consistent dividend coverage, and strong credit quality, while acknowledging competitive market conditions and shifts …
Trinity Capital (TRIN) reported record Q2 originations and growth in net asset value, driven by an expanding managed-funds platform, equipment-finance acquisition, and joint ventures. The company's net investment income reached $41.6 million ($0.51 per share), covering its quarterly distribution, and its net asset value …
Trinity Capital Inc. (TRIN) reported its Q2 investment income of $87.2 million, falling short of FactSet's estimate of $91.4 million. The company's net investment income for the quarter was $0.51 per share, slightly below the FactSet estimate of $0.52 per share. Trinity Capital recently …
Trinity Capital (TRIN) reported Q2 earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.52, and revenues of $87.17 million, falling short of the $90.99 million estimate. Despite the quarterly miss, the company's shares have risen approximately 24% year-to-date, outperforming the S&P …
UBS has reiterated its 'buy' rating for Rentokil Initial PLC (LSE:RTO) after a meeting with the pest control group's new chief executive, citing a sharply positive risk-reward skew following the recent selloff. The bank maintains its 480p price target, suggesting a 35% upside, despite …
This article provides a brief overview of Trinity Capital Inc.'s 7.875% Notes Due 2029 (NYSE: TRNI) on TradingView. It highlights that investors can find key financial statistics and ratios such as market capitalization, P/E Ratio, EPS, and ROI on the platform. The content primarily …
Trinity Capital Inc. reported strong financial results for the second quarter of 2026, with total investment income increasing by 25.5% year-over-year to $87.2 million and net investment income reaching a record $46.0 million, or $0.51 per share. The company funded $618.7 million in new …
Segall Bryant & Hamill LLC recently acquired 49,303 shares of Trinity Industries (NYSE:TRN), valued at approximately $1.59 million, giving it a 0.06% stake in the company. Institutional investors and hedge funds collectively own 86.57% of Trinity Industries, with several other funds also adjusting their …
Bank of America Corp DE significantly increased its stake in Rentokil Initial PLC (NYSE:RTO) during the first quarter, purchasing over 2.5 million additional shares, bringing their total holdings to 1.32% of the company. Rentokil Initial shares opened at $25.07, below their moving averages, and …
BofA Securities has initiated coverage on Rentokil Initial PLC (RTO.US) with a "Buy" rating. This indicates a positive outlook from the investment bank regarding the company's stock performance.
The move puts the specialty business-services group under renewed scrutiny after a sharp multiweek reset.
This article provides financial data for bioAffinity Technologies, Inc. (NASDAQ: BIAF), specifically its Enterprise Value to EBIT forward. The content is presented through TradingView, offering an overview of financials, news, and community sentiment for the company. The data is supplied by ICE Data Services …
Search by ticker symbol or company name and select a result to open its chart.